From: Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
3 years | 10 years | ||||
---|---|---|---|---|---|
Variable | Definition | RR (95% CI) | P | RR (95% CI) | P |
Center | VGH | 1. | 1. | ||
JGH | 0.67 [0.35; 1.31] | .25 | 0.76 [0.51; 1.13] | .17 | |
Age of diagnosis | < 50 years | 1. | 1. | ||
≥ 50 years | 1.10 [0.55; 2.16] | .79 | 0.97 [0.66; 1.44] | .89 | |
Histological grade*, § | 1 | 1. | 1. | ||
2 | 2.62 [0.88; 7.80] | .08 | 1.63 [0.97; 2.73] | .06 | |
3 | 5.47 [1.84; 16.2] | .002 | 2.37 [1.36; 4.11] | .002 | |
Tumor Size § | < 2 cm | 1. | 1. | ||
≥ 2 cm | 3.22 [1.42; 7.32] | .005 | 2.82 [1.78; 4.46] | .0001 | |
Lymph nodes § | No | 1. | 1. | ||
Yes | 2.78 [1.37; 5.65] | .005 | 2.21 [1.46; 3.32] | .0002 |